Search

AtriCure Inc

Fermé

SecteurSoins de santé

58.13 -1.21

Résumé

Variation du prix de l'action

24h

Actuel

Min

57.67

Max

59.79

Chiffres clés

By Trading Economics

Revenu

8.8M

9M

Ventes

12M

154M

P/E

Moyenne du Secteur

265.667

56.432

BPA

0.18

Marge bénéficiaire

5.83

Employés

1,350

EBITDA

-3.8M

3.2M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

-5.34% downside

Dividendes

By Acuity

Prochains Résultats

28 oct. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

1.1B

2.8B

Ouverture précédente

59.34

Clôture précédente

58.13

Sentiment de l'Actualité

By Acuity

34%

66%

56 / 339 Classement par Healthcare

AtriCure Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

18 sept. 2026, 20:02 UTC

AtriCure Inc shares fell sharply, breaking a recent pattern of higher daily closes amid unusually high market volume.

17 sept. 2026, 20:07 UTC

AtriCure Inc is advancing in today's trading session, continuing a trend that has seen the stock rise significantly since Wednesday's close.

16 sept. 2026, 19:44 UTC

AtriCure Inc is trading higher, maintaining a price above its 20-day moving average and marking gains in four consecutive sessions.

15 sept. 2026, 20:07 UTC

News

AtriCure Inc's stock is higher following an insider sale of 5,313 shares by Board Member Regina E. Groves for about $288,070.

14 sept. 2026, 20:07 UTC

News

AtriCure reports gross revenue of $534.53 million and a net income loss of $11.45 million, with shares advancing amid positive market sentiment.

11 sept. 2026, 22:11 UTC

AtriCure Inc. shares are lower in after-market trading, continuing a decline since Friday's close amid notably weak overall market conditions.

9 sept. 2026, 20:07 UTC

AtriCure Inc. shares are lower today, following a notable drop at the open amid broader market volatility. No specific news was identified for the decline.

8 sept. 2026, 20:01 UTC

News

AtriCure Inc. is trading higher as analysts issue mixed ratings and price targets, with BTIG raising its target to $55.00.

3 sept. 2026, 20:01 UTC

AtriCure Inc shares are lower during Thursday's session, continuing a decline since Wednesday. No specific news was identified to explain the movement.

2 sept. 2026, 20:01 UTC

News

AtriCure Inc shares are higher following an upgrade from Needham, raising the price target to $64.00 from $45.00 while maintaining a Buy rating.

1 sept. 2026, 20:08 UTC

AtriCure Inc. shares are higher today, driven by gains in the Health Care Equipment sub-sector. The stock remains strong above its 20-day moving average.

31 août 2026, 19:26 UTC

AtriCure Inc's shares are lower amid broader market sentiment influenced by interest rate concerns, despite remaining above their 20-day moving average.

28 août 2026, 19:16 UTC

AtriCure Inc shares are lower today, following an early dip. Broader market concerns about inflation and growth expectations may be influencing sentiment.

26 août 2026, 19:08 UTC

News

AtriCure Inc shares are lower amid Health Care Equipment sector weakness and an insider sale of 9,370 shares valued at $458,099.

24 août 2026, 19:36 UTC

News

AtriCure's price target raised to $55 from $45 by BTIG. Shares are higher, reflecting positive sentiment on the company's growth prospects.

20 août 2026, 19:46 UTC

AtriCure Inc shares are higher today, maintaining gains since Wednesday's close, despite earlier fluctuations. The stock remains above its 20-day moving average.

19 août 2026, 20:01 UTC

AtriCure Inc shares are trading higher during Wednesday's session, continuing a strong upward trajectory since Tuesday's close, despite no specific news identified.

18 août 2026, 19:16 UTC

AtriCure Inc shares are higher today, continuing momentum from Monday's close. Broader market factors include rising U.S. Treasury yields amid inflation concerns.

17 août 2026, 22:46 UTC

AtriCure Inc is trading higher in after-market hours, with no specific news identified for the move. The stock remains above its 20-day moving average.

12 août 2026, 20:06 UTC

AtriCure Inc shares are higher today, continuing a nine-session streak of gains. The stock remains above its 20-day moving average.

11 août 2026, 22:41 UTC

AtriCure Inc shares are higher in after-market trading, continuing a recent trend of strength amid changing monetary policies from central banks.

7 août 2026, 20:03 UTC

AtriCure Inc's shares are higher during Friday's session, continuing an upward trend since Thursday's close, and remain above their 20-day moving average.

6 août 2026, 19:12 UTC

AtriCure Inc shares are higher, benefiting from an upward trend in the Health Care Equipment sub-sector. Earlier, the stock peaked before a slight pullback.

5 août 2026, 19:51 UTC

AtriCure Inc shares are higher today, despite no specific news. Broader market sentiment is cautious following ADP's disappointing employment report.

3 août 2026, 20:06 UTC

AtriCure Inc. shares are higher during Monday's session, regaining ground after an earlier pullback. Broader market trends support positive investor sentiment.

31 juil. 2026, 20:03 UTC

News

AtriCure shares are lower amid significant insider selling, including a $233,280 sale by Chief Scientific Officer Vinayak Doraiswamy and options exercised by Board Member Sven Wehrwein.

30 juil. 2026, 18:56 UTC

AtriCure Inc's shares are lower today, impacted by declines in the Health Care Equipment sub-sector. No specific company news was identified for the movement.

29 juil. 2026, 20:03 UTC

News

AtriCure Inc shares reached a 52-week high of $43.18 following better-than-expected quarterly earnings, despite a pullback earlier in the session.

28 juil. 2026, 19:21 UTC

AtriCure Inc's shares are higher today amid stronger gains in U.S. and European indices, with no specific company news identified for the movement.

27 juil. 2026, 20:02 UTC

News

AtriCure Inc shares are higher as the company prepares for two investor conferences and highlights CEO Michael Carrel's leadership appointment.

Comparaison

Variation de prix

AtriCure Inc prévision

Objectif de Prix

By TipRanks

-5.34% baisse

Prévisions sur 12 Mois

Moyen 55 USD  -5.34%

Haut 65 USD

Bas 36 USD

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

8 ratings

6

Achat

2

Maintien

0

Vente

Sentiment

By Acuity

56 / 339Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos AtriCure Inc

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.